Patents by Inventor Zhaobai ZHONG

Zhaobai ZHONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitor
    Patent number: 10829492
    Abstract: Provided is an amino pyrazolopyrimidine compound as represented by the following structural formula used as a neurotrophic factor tyrosine kinase receptor inhibitor. The compound can inhibit the activity of Trk kinase and can treat diseases mediated by a Trk tyrosine kinase receptor in mammals.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: November 10, 2020
    Assignees: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD., CENTAURUS BIOPHARMA CO., LTD., LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD.
    Inventors: Li Zhu, Yuandong Hu, Wei Wu, Liguang Dai, Xiaowei Duan, Yanqing Yang, Yinghui Sun, Yongxin Han, Yong Peng, Fansheng Kong, Hong Luo, Ling Yang, Hongjiang Xu, Meng Guo, Zhaobai Zhong, Shanchun Wang
  • AMINO PYRAZOLOPYRIMIDINE COMPOUND USED AS NEUROTROPHIC FACTOR TYROSINE KINASE RECEPTOR INHIBITOR
    Publication number: 20190352306
    Abstract: Provided is an amino pyrazolopyrimidine compound as represented by the following structural formula used as a neurotrophic factor tyrosine kinase receptor inhibitor. The compound can inhibit the activity of Trk kinase and can treat diseases mediated by a Trk tyrosine kinase receptor in mammals.
    Type: Application
    Filed: October 27, 2017
    Publication date: November 21, 2019
    Inventors: Li ZHU, Yuandong HU, Wei WU, Liguang DAI, Xiaowei DUAN, Yanqing YANG, Yinghui SUN, Yongxin HAN, Yong PENG, Fansheng KONG, Hong LUO, Ling YANG, Hongjiang XU, Meng GUO, Zhaobai ZHONG, Shanchun WANG